Australia, May 26 -- Eagle Pharmaceuticals Inc., owns the trademark (2601284) for 'FAZDI' till July 25, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceuticals for the treatment of cancer.]
Type of Mark: Word
Date of Acceptance: Feb. 6
Registration Advertised: May 25
For further details contact John M. Mueller Baker & Hostetler LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2601284.
Disclaimer: Curated by HT Syndication.
